Shivalik Rasayan proposes ₹33 crore preferential share and warrant issue
Shivalik Rasayan Limited approved a ₹33 crore preferential issue comprising 3,72,000 equity shares and 9,48,000 warrants at ₹250 each. The Board approved the plan on July 23, 2026, with an EGM set for August 20, 2026, to seek shareholder approval for the capital raise.
*this image is generated using AI for illustrative purposes only.
Shivalik Rasayan Limited has initiated a capital raising exercise worth up to ₹33 crore through a preferential allotment of equity shares and fully convertible warrants (FCWs). The company’s Board of Directors approved the issuance during a meeting held on July 23, 2026, aiming to strengthen its capital base for future growth initiatives. This move signals the company’s intent to leverage both equity and debt-like instruments to fund operations while offering investors flexible entry points.
The proposal involves issuing up to 3,72,000 Equity Shares with a face value of ₹5 each at an issue price of ₹250 per share, aggregating to ₹9.30 crore. Simultaneously, the company plans to allot up to 9,48,000 FCWs at the same price point of ₹250 per warrant, totaling ₹23.70 crore. Both instruments are priced in accordance with Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and relevant provisions of the Companies Act, 2013.
Equity Share Allotment Details
The equity shares are being offered to public category investors. The allocation is distributed among five entities, primarily involving individual investors and joint holdings.
| Name of Proposed Allottees | Category | No. of Equity Shares |
|---|---|---|
| Harish Pande Jt. Usha Pande | Public | 60,000 |
| Ashwani Kumar Sharma | Public | 1,32,000 |
| Usha Pande Jt. Harish Pande | Public | 60,000 |
| Deepa Pande | Public | 60,000 |
| Jaideep Mahesh Chandra Dwivedi | Public | 60,000 |
| Total | 3,72,000 |
Warrant Issuance Structure
The fully convertible warrants are convertible into an equivalent number of equity shares of face value ₹5 each. Holders may convert these warrants in one or more tranches within 18 months from the date of allotment. The allottees include both promoter group entities and public investors.
| Name of Proposed Allottees | Category | No. of Warrants |
|---|---|---|
| Growel Remedies Limited | Promoter | 4,28,000 |
| Bishnoi Exports Private Limited | Public | 1,20,000 |
| Ginnerup Capital ApS | Public | 4,00,00 |
| Total | 9,48,000 |
Regulatory Approvals and Timeline
The issuance is subject to approval by the shareholders and applicable regulatory authorities. Shivalik Rasayan Limited has scheduled an Extra-Ordinary General Meeting (EGM) for Thursday, August 20, 2026, to seek shareholder consent for the preferential issue and other connected matters. The company has appointed Mr. Manoj Kumar Jain, Practicing Company Secretary (M. No.: 5832, COP No.: 5629), as the scrutinizer for the remote e-voting process associated with the EGM.
This disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. A Preferential Issue Committee has been constituted to finalize all relevant documents necessary for the completion of the process.
Historical Stock Returns for Shivalik Rasayan
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.27% | +12.47% | +10.31% | -24.85% | -56.99% | -74.69% |
What specific growth initiatives or capital expenditures is Shivalik Rasayan planning to fund with the ₹33 crore raised through this preferential allotment?
How might the conversion of 9,48,000 FCWs into equity shares over the next 18 months impact the company's existing promoter holding and overall market capitalization?
What are the strategic implications of Growel Remedies Limited, a promoter entity, taking the largest stake in the warrant issuance compared to public investors?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
